Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 215

The DOI matches its Crossref record.

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome

Open access
Gross, TG, Steinbuch, M, DeFor, T, Shapiro, RS, McGlave, P, Ramsay, NKC, Wagner, JE, Filipovich, AH·1999·Bone Marrow Transplantation

Abstract

Twenty-six cases of B cell lymphoproliferative disorder (BLPD) were identified among 2395 patients following hematopoietic stem cell transplants (HSCT) for which an overall incidence of BLPD was 1.2%. The true incidence was probably higher, since 9/26 of the diagnoses were made at autopsy. No BLPD was observed following autologous HSCT, so risk factor analyses were confined to the 1542 allogeneic HSCT. Factors assessed were HLA-mismatching (⩾1 antigen), T cell depletion (TCD), presence of acute GvHD (grades II–IV), donor type (related vs unrelated), age of recipient and donor, and underlying disease. Factors found to be statistically significant included patients transplanted for immune deficiency and CML, donor age ⩾18 years, TCD, and HLA-mismatching, with recipients of combined TCD and HLA-mismatched grafts having the highest incidence. Factors found to be statistically significant in a multiple regression analysis were TCD, donor age and immune deficiency, although 7/8 of the patients with immunodeficiencies and BLPD received a TCD graft from a haploidentical parent. The overall mortality was 92% (24/26). One patient had a spontaneous remission, but subsequently died >1 year later of chronic GVHD. Thirteen patients received therapy for BLPD. Three patients received lymphocyte infusions without response. The only patients with responses and long-term survival received alpha interferon αIFN). Of seven patients treated with αIFN there were four responses (one partial and three complete). These data demonstrate thatαIFN can be an effective agent against BLPD following HSCT, if a timely diagnosis is made.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bmt.1701554

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 215

Metadata

Authors
Gross, T., Steinbuch, M., DeFor, T., Shapiro, R., McGlave, P., Ramsay, N., Wagner, J., & Filipovich, A.
Venue
Bone Marrow Transplantation
Published
1999-02-01
Volume
23
Issue
3
Pages
251-258
ISSN
  • 0268-3369 (ISSN-L)
  • 1476-5365
OpenAlex
W2061048050
Cited by
215
References
0
FWCI
8.81
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. https://app.cochat.ai/papers/10.1038/sj.bmt.1701554
The paper
Gross, T., Steinbuch, M., DeFor, T., Shapiro, R., McGlave, P., Ramsay, N., Wagner, J., & Filipovich, A. (1999). B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplantation. https://doi.org/10.1038/sj.bmt.1701554

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.